Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TruCan Ultra Lyme-L4
- Development stage
- Unknown
- Lead developer
- Elanco
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
TruCan Ultra Lyme-L4 is a USDA-approved veterinary combination vaccine developed by Elanco. It is the first and only 1/2 mL combination vaccine designed to protect dogs against both Lyme disease (caused by *Borrelia burgdorferi*) and leptospirosis (caused by *Leptospira* spp. serovars) in a single low-volume dose. Formulated using Elanco's proprietary PureFil™ Technology, the vaccine is highly purified to reduce vaccination reactions associated with unwanted proteins and cellular debris, thereby improving patient comfort and reducing stress during veterinary visits. By combining two essential annual vaccinations into a single injection, TruCan Ultra Lyme-L4 helps close critical protection gaps for dogs at risk of these prevalent infectious diseases.
- Brand names
- TruCan Ultra Lyme-L4
- Other names
- TruCan™ Ultra Lyme-L4
Beyond the preview
Go deeper on TruCan Ultra Lyme-L4.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TruCan Ultra Lyme-L4.